Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 21641867

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2011 Jul
First author
Adams RA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2011 Jun 28;8(8):448. doi: 10.1038/nrclinonc.2011.98.
    note
    Source null
    related pmid
    21709694
    relationship
    Comment in

Authors and identifiers

  1. name
    Adams RA
    type
    Author
  2. name
    Meade AM
    type
    Author
  3. name
    Seymour MT
    type
    Author
  4. name
    Wilson RH
    type
    Author
  5. name
    Madi A
    type
    Author
  6. name
    Fisher D
    type
    Author
  7. name
    Kenny SL
    type
    Author
  8. name
    Kay E
    type
    Author
  9. name
    Hodgkinson E
    type
    Author
  10. name
    Pope M
    type
    Author
  11. name
    Rogers P
    type
    Author
  12. name
    Wasan H
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Adams RA
    type
    Author
  2. name
    Meade AM
    type
    Author
  3. name
    Seymour MT
    type
    Author
  4. name
    Wilson RH
    type
    Author
  5. name
    Madi A
    type
    Author
  6. name
    Fisher D
    type
    Author
  7. name
    Kenny SL
    type
    Author
  8. name
    Kay E
    type
    Author
  9. name
    Hodgkinson E
    type
    Author
  10. name
    Pope M
    type
    Author
  11. name
    Rogers P
    type
    Author
  12. name
    Wasan H
    type
    Author
bibliography ids
  1. nci-bib-5763381d557e52d73e4efee6
book metadata
content sha256
6e2a125c220b328ea868e927b62b3cbe6664d5dd4b205767f01fb30ea72119ee
document type
citation
dois
  1. 10.1016/S1470-2045(11)70102-4
electronic publication date
display
2011 Jun 5
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21641867
immutable id
pubmed:21641867@6e2a125c220b328ea868e927b62b3cbe6664d5dd4b205767f01fb30ea72119ee
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
642-53
volume
12
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2011 Jun 28;8(8):448. doi: 10.1038/nrclinonc.2011.98.
    note
    Source null
    related pmid
    21709694
    relationship
    Comment in
outcomes validated
false
pmid
21641867
provenance
batch id
a366a1bc8ed89d8d7ca5
provider
NCBI PubMed ESummary
record sha256
da1f528a31c69541a082a91a10079fb73d672568da4fdc6a06df498dd598b999
response sha256
c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
retrieved at
2026-09-09T23:46:40.540025+00:00
publication date
display
2011 Jul
precision
month
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21641867/
title
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Preserved source evidence · Independent clinical review pending · Not medical advice